Open AccessNanoparticle-linked antagonist for leptin signaling inhibition in breast cancer
Author(s) -
Tia L. Harmon,
Adriana Harbuzariu,
Viola Lanier,
Crystal C. Lipsey,
Ward G. Kirlin,
Lily Yang,
Ruben R. Gonzalez-Perez
Publication year - 2017
Publication title -
world journal of clinical oncology
Language(s) - English
Resource type - Journals
ISSN - 2218-4333
DOI - 10.5306/wjco.v8.i1.54
Subject(s) - leptin , antagonist , breast cancer , cancer research , estrogen receptor , medicine , triple negative breast cancer , survivin , cancer , cyclin d1 , western blot , pharmacology , endocrinology , receptor , cell cycle , chemistry , biochemistry , obesity , gene
To develop a leptin peptide receptor antagonist linked to nanoparticles and determine its effect on viability of breast cancer cells.